A Study Of Laser Acupuncture Effects In Fibromyalgia

Overview

About this study

The purpose of this study is to assess the feasibility of offering laser acupuncture to fibromyalgia patients by comparing study completion rates to initial enrollment.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Ages 18 years of age to 65 years.

  • Has been assessed at the General Internal Medicine Fibromyalgia & Chronic Fatigue Clinic within 12 months of study start (signing consent).

  • Has a diagnosis of fibromyalgia (per ACR2016 criteria).

  • Has at least 11 tender points (per 1990 criteria).

  • Self-reported pain intensity as reported at baseline of 4 or above on the VAS scale (PROMIS Numeric Rating Scale).

  • Is on stable medications (unchanged for the 4 weeks prior to study start – signing consent-).

  • Is able to participate fully in all aspects of the study.

  • Can understand and sign the study informed consent.

  • Apart from fibromyalgia and tender point pain, the individual is considered in good health based on assessment by the clinical investigators.

Exclusion Criteria: 

  • Used new pain medications (excluding NSAIDs or acetaminophen) or received pain treatment within three days before enrollment.

  • Has an implanted device (including a lap band) in the targeted area of laser acupuncture

  • Has used an investigational drug within 30 days of study enrollment.

  • Reports being pregnant, lactating, or of child-bearing potential at the start of the study (signing consent) or are likely to become pregnant during the laser acupuncture treatment phase (please note:    Pregnancy testing is available upon request for study participants).

  • Has a history of any major cardiovascular events, including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease.

  • Has clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, metabolic disease (such as uncontrolled type 2 diabetes)

  • Has a diagnosis of psychiatric disorders such as psychosis, bipolar disorder, or schizophrenia

  • Has active cancer, actively receiving treatment for cancer or within 1 year of cancer remission.

  • Has had surgical intervention for pain within 1 month prior to enrollment.

  • Has an active infection, wound or other external trauma to the areas to be treated with the laser.

  • Has a known photosensitivity disorder.

  • Has a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 02/23/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Tony Chon, M.D.

Contact us for the latest status

Contact information:

Shawn Fokken

5072932740

fokken.shawn@mayo.edu

More information

Publications

Publications are currently not available